Skip to main content
SpringerLink
Log in

Inflammation, Obsessive-Compulsive Disorder, and Related Disorders

  • Chapter
  • First Online:
The Neurobiology and Treatment of OCD: Accelerating Progress

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 49))

Abstract

Initial reports supporting the possibility of inflammation in the brain in obsessive-compulsive disorder (OCD) evolved from the models of Sydenham’s Chorea, and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS), which implicated excessive autoimmune responses following exposure to group A B-hemolytic streptococcal infections. Subsequently, this model was expanded to Pediatric Autoimmune Neuropsychiatric Syndrome (PANS) which applied the same concept but included other infections. A critical shortcoming of this model was that it was attributable to a small minority of OCD cases. The relationship between inflammation and OCD was more broadly demonstrated through translocator protein (TSPO) positron emission tomography imaging, a method that detects gliosis, an important component of brain inflammation, in neuropsychiatric diseases, including morphological activation and proliferation of microglia and to some extent astroglia. This method identified greater TSPO binding in the cortico-striatal-thalamo-cortical circuit in OCD, providing a direct brain measure of an important component of inflammation. To identify OCD cases with prominent elevations in TSPO binding in clinical research settings with lower cost peripheral markers, a promising approach is to apply blood serum biomarkers of inflammatory molecules produced by activated microglia and astroglia (gliosis). Such measures may aid stratification in future clinical trials. Several inflammatory-modifying interventions, including celecoxib, minocycline, and n-acetylcysteine, have been tested as treatments in randomized double-blind placebo controlled clinical trials and there is a tendency toward positive results, although these medications are not optimized for brain penetration and sample sizes for most trials were small. Future clinical trials of medications that target gliosis in OCD should apply larger sample sizes, ideally incorporating stratification approaches to enrich samples for the presence of gliosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8(3):391–401

    Article  CAS  PubMed  Google Scholar 

  • Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, Sadeghi M, Hafezian H (2012) N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 32(6):797–803

    Article  CAS  PubMed  Google Scholar 

  • Akanuma S, Higuchi T, Higashi H, Ozeki G, Tachikawa M, Kubo Y, Hosoya K (2014) Transporter-mediated prostaglandin E(2) elimination across the rat blood-brain barrier and its attenuation by the activation of N-methyl-D-aspartate receptors. Drug Metab Pharmacokinet 29(5):387–393

    Article  PubMed  CAS  Google Scholar 

  • Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C, Johayem A, Mancilla BG, Sovago J, Buck A, Hasler G (2014) Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 17(12):1915–1922

    Article  CAS  PubMed  Google Scholar 

  • Attwells S, Setiawan E, Wilson AA, Rusjan P, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiat 74:833–840

    Article  Google Scholar 

  • Attwells S, Setiawan E, Wilson AA, Rusjan PM, Miler L, Xu C, Hutton C, Husain MI, Kish S, Vasdev N, Houle S, Meyer JH (2020a) Replicating predictive serum correlates of greater translocator protein distribution volume in brain. Neuropsychopharmacology 45(6):925–931

    Article  CAS  PubMed  Google Scholar 

  • Attwells S, Setiawan E, Rusjan PM, Xu C, Hutton C, Rafiei D, Varughese B, Kahn A, Kish SJ, Vasdev N, Houle S, Meyer JH (2020b) Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder. Biol Psychiatry 88(8):649–656. https://doi.org/10.1016/j.biopsych.2020.03.007

    Article  CAS  PubMed  Google Scholar 

  • Bachen EA, Chesney MA, Criswell LA (2009) Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 61:822–829

    Article  PubMed  PubMed Central  Google Scholar 

  • Banati R, Myers R, Kreutzberg GW (1997) PK (‘peripheral benzodiazepine’)--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol 26:77–82

    Article  CAS  PubMed  Google Scholar 

  • Banks WA (2015) The blood-brain barrier in neuroimmunology: Tales of separation and assimilation. Brain Behav Immun 44:1–8

    Article  CAS  PubMed  Google Scholar 

  • Beltazar C, Harrison-Brown M, Middleton RJ, Banati R, Liu GJ (2018) Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain. Int J Mol Sci 19:E2707

    Article  CAS  Google Scholar 

  • Berk M, Malhi GS, Gray LJ, Dean OM (2013) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34(3):167–177

    Article  CAS  PubMed  Google Scholar 

  • Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK (2009) Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology 34(12):2489–2496

    Article  CAS  PubMed  Google Scholar 

  • Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11(7):622–632

    Article  CAS  PubMed  Google Scholar 

  • Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57–69

    Article  CAS  PubMed  Google Scholar 

  • Brown KD, Farmer C, Freeman GM Jr, Spartz EJ, Farhadian B, Thienemann M, Frankovich J (2017) Effect of early and prophylactic nonsteroidal anti-inflammatory drugs on flare duration in pediatric acute-onset neuropsychiatric syndrome: an observational study of patients followed by an academic community-based pediatric acute-onset neuropsychiatric syndrome clinic. J Child Adolesc Psychopharmacol 27(7):619–628

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV (1999) Persistent Sydenham’s chorea. Mov Disord 14(5):805–807

    Article  CAS  PubMed  Google Scholar 

  • Cheng S, Hou J, Zhang C, Xu C, Wang L, Zou X, Yu H, Shi Y, Yin Z, Chen G (2015) Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration. Sci Rep 5:10535

    Article  PubMed  PubMed Central  Google Scholar 

  • Clark SM, Pocivavsek A, Nicholson JD, Notarangelo FM, Langenberg P, McMahon RP, Kleinman JE, Hyde TM, Stiller J, Postolache TT, Schwarcz R, Tonelli LH (2016) Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. J Psychiatry Neurosci 41(6):386–394

    Article  PubMed  PubMed Central  Google Scholar 

  • Converse AK, Larsen EC, Engle JW, Barnhart TE, Nickles RJ, Duncan ID (2011) 11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats. J Nucl Med 52(2):257–262

    Article  PubMed  Google Scholar 

  • Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Matthew Prina A, Maes M, Stein DJ, Stubbs B, Carvalho AF (2019) Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol 56(7):4751–4759

    Article  CAS  PubMed  Google Scholar 

  • Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 35:306–328

    Article  CAS  PubMed  Google Scholar 

  • Cosgrove KP (2013) Personal communication from Hannestad et al. The neuroinflamation marker translocator protein is not elevated in individuals with mild to moderate depression: a [11C]PBR28 PET study. Brain Behav Immun 33:131–138

    Article  CAS  Google Scholar 

  • Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG (2017) Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 78(7):e766–e773

    Article  PubMed  Google Scholar 

  • Dale RC, Heyman I, Giovannoni G, Church AW (2005) Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 187:314–319

    Article  PubMed  Google Scholar 

  • Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dean SL, Singer HS (2017) Treatment of Sydenham’s chorea: a review of the current evidence. Tremor Other Hyperkinet Mov 7:456

    Article  Google Scholar 

  • Emery ES, Vieco PT (1997) Sydenham chorea: magnetic resonance imaging reveals permanent basal ganglia injury. Neurology 48(2):531–533

    Article  CAS  PubMed  Google Scholar 

  • Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24–40

    Article  PubMed  Google Scholar 

  • Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S (2016) Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: a placebo-controlled, double-blind, randomized trial. Psychiatry Clin Neurosci 70(11):517–526

    Article  CAS  PubMed  Google Scholar 

  • Fettes P, Schulze L, Downar J (2017) Cortico-striatal-thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness. Front Syst Neurosci 11:25

    Article  PubMed  PubMed Central  Google Scholar 

  • Galasko D, Montine TJ (2010) Biomarkers of oxidative damage and inflammation in Alzheimer’s disease. Biomark Med 4(1):27–36

    Article  CAS  PubMed  Google Scholar 

  • Garrido-Mesa N, Zarzuelo A, Galvez J (2013) Minocycline: far beyond an antibiotic. Br J Pharmacol 169(2):337–352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gause C, Morris C, Vernekar S, Pardo-Villamizar C, Grados MA, Singer HS (2009) Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol 214(1–2):118–124

    Article  CAS  PubMed  Google Scholar 

  • Ghanizadeh A, Mohammadi MR, Bahraini S, Keshavarzi Z, Firoozabadi A, Alavi SA (2017) Efficacy of N-acetylcysteine augmentation on obsessive compulsive disorder: a multicenter randomized double blind placebo controlled clinical trial. Iran J Psychiatry 12(2):134–141

    PubMed  PubMed Central  Google Scholar 

  • Hagen AA, Gerber JN, Sweeley CC, White RP, Robertson JT (1977) Levels and disappearance of prostaglandin F2alpha in cerebral spinal fluid: a clinical and experimental study. Stroke 8(6):672–675

    Article  CAS  PubMed  Google Scholar 

  • Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knupfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 14(5):606–617

    Article  CAS  PubMed  Google Scholar 

  • Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Oz G, Cloyd JC, Tuite PJ (2013) N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clin Neuropharmacol 36(4):103–106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM, Gerhard A, Talbot PS (2018) Elevated Translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 83(1):61–69

    Article  CAS  PubMed  Google Scholar 

  • Homsi S, Piaggio T, Croci N, Noble F, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M (2010) Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study. J Neurotrauma 27(5):911–921

    Article  PubMed  Google Scholar 

  • Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG (2019) PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc Natl Acad Sci U S A

    Google Scholar 

  • Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC Jr (1976) Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 144(4):1094–1110

    Article  CAS  PubMed  Google Scholar 

  • Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW, Innis RB (2017) Biomarkers consortium Radioligand project T. 11C-ER176, a Radioligand for 18-kDa Translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58(2):320–325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL, Ruetzler C, Chuang DM, Pike VW, Innis RB, Fujita M (2007) PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411(3):200–205

    Article  CAS  PubMed  Google Scholar 

  • Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188(1):21–28

    Article  CAS  PubMed  Google Scholar 

  • Kiessling LS, Marcotte AC, Culpepper L (1994) Antineuronal antibodies: tics and obsessive-compulsive symptoms. J Dev Behav Pediatr 15(6):421–425

    Article  CAS  PubMed  Google Scholar 

  • Kim MJ, Shrestha SS, Cortes M, Singh P, Morse C, Liow JS, Gladding RL, Brouwer C, Henry K, Gallagher E, Tye GL, Zoghbi SS, Fujita M, Pike VW, Innis RB (2018) Evaluation of two potent and selective PET radioligands to image COX-1 and COX-2 in rhesus monkeys. J Nucl Med 59(12):1907–1912

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003a) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9(7):914–920

    Article  CAS  PubMed  Google Scholar 

  • Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003b) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914–920

    Article  CAS  PubMed  Google Scholar 

  • Kirvan CA, Swedo SE, Kurahara D, Cunningham MW (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity 39(1):21–29

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A, Ishiguro N, Kadomatsu K (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 4:e525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kobayashi M, Jiang T, Telu S, Zoghbi SS, Gunn RN, Rabiner EA, Owen DR, Guo Q, Pike VW, Innis RB, Fujita M (2018) 11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-( R)-PK11195. J Cereb Blood Flow Metab 38:393–403

    Article  CAS  PubMed  Google Scholar 

  • Kumar JSD, Bai B, Zanderigo F, DeLorenzo C, Prabhakaran J, Parsey RV, Mann JJ (2018) In vivo brain imaging, biodistribution, and radiation dosimetry estimation of [(11)C]Celecoxib, a COX-2 PET ligand, in nonhuman primates. Molecules 23(8)

    Google Scholar 

  • Latimer ME, L’Etoile N, Seidlitz J, Swedo SE (2015) Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Child Adolesc Psychopharmacol 25(1):70–75

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee JL, Naguwa SM, Cheema GS, Gershwin ME (2009) Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmun Rev 9(2):117–123

    Article  PubMed  Google Scholar 

  • Li H, Sagar AP, Keri S (2018) Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 83:1–7

    Article  CAS  Google Scholar 

  • Li F, Welling MC, Johnson JA, Coughlin C, Mulqueen J, Jakubovski E, Coury S, Landeros-Weisenberger A, Bloch MH (2020) N-acetylcysteine for pediatric obsessive-compulsive disorder: a small pilot study. J Child Adolesc Psychopharmacol 30(1):32–37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lisboa BCG, Oliveira KC, Tahira AC, Barbosa AR, Feltrin AS, Gouveia G, Lima L, Feio Dos Santos AC, Martins DC Jr, Puga RD, Moretto AC, De Braganca Pereira CA, Lafer B, Leite REP, Ferretti-Rebustini REL, Farfel JM, Grinberg LT, Jacob-Filho W, Miguel EC, Hoexter MQ, Brentani H (2019) Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysis. Sci Rep 9(1):3086

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB, CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (2015) Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85:1972–1979

    Article  PubMed  PubMed Central  Google Scholar 

  • Martin A, Boisgard R, Thézé B, van Camp N, Kuhnast B, Damont A, Kassiou M, Dolié F, Tavitian B (2010) Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J Cereb Blood Flow Metab 30:230–241

    Article  CAS  PubMed  Google Scholar 

  • Martin A, Boisgard R, Kassiou M, Dolle F, Tavitian B (2011) Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714. Mol Imaging Biol 13(1):10–15

    Article  PubMed  Google Scholar 

  • Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, Kosaka J, Arakawa R, Fujimura Y, Ota M, Takano A, Fukui K, Nakayama K, Suhara T (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. NeuroImage 49(1):121–126

    Article  PubMed  Google Scholar 

  • Meyer J (2017) Novel phenotypes detectable with PET in mood disorders: elevated monoamine oxidase A and Translocator protein level. In: Vasdev N, Alavi A (eds) PET clinics: novel PET radiotracers with potential clinical applications, vol 12. Elsevier, pp 361–371

    Google Scholar 

  • Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB (2020) Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry 7(12):1064–1074

    Article  PubMed  PubMed Central  Google Scholar 

  • Minghetti L, Polazzi E, Nicolini A, Creminon C, Levi G (1997) Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci 9(5):934–940

    Article  CAS  PubMed  Google Scholar 

  • Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N (2018) Emerging PET radiotracers and targets for imaging of Neuroinflammation in neurodegenerative diseases: outlook beyond TSPO. Mol Imaging 17:1536012118792317

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nicholson TR, Ferdinando S, Krishnaiah RB, Anhoury S, Lennox BR, Mataix-Cols D, Cleare A, Veale DM, Drummond LM, Fineberg NA, Church AJ, Giovannoni G, Heyman I (2012) Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study. Br J Psychiatry 200(5):381–386

    Article  PubMed  Google Scholar 

  • Nicolini H, Lopez Y, Genis-Mendoza AD, Manrique V, Lopez-Canovas L, Niubo E, Hernandez L, Bobes MA, Riveron AM, Lopez-Casamichana M, Flores J, Lanzagorta N, De la Fuente-Sandoval C, Santana D (2015) Detection of anti-streptococcal, antienolase, and anti-neural antibodies in subjects with early-onset psychiatric disorders. Actas Esp Psiquiatr 43(2):35–41

    PubMed  Google Scholar 

  • Owen DR, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, Galloway D, Williams JB, Lehr J, Mandhair H, Peferoen LA, Taylor PC, Amor S, Antel JP, Matthews PM, Moore CS (2017) Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans. J Cereb Blood Flow Metab 37(8):2679–2690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paydary K, Akamaloo A, Ahmadipour A, Pishgar F, Emamzadehfard S, Akhondzadeh S (2016) N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 41(2):214–219

    Article  CAS  PubMed  Google Scholar 

  • Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314–332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James R, Gao H, Kichuk SA, Simpson R, Billingslea E, Hannestad J, Bloch M, Mayes L, Bhagwagar Z, Carson RE (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87–96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Plane JM, Shen Y, Pleasure DE, Deng W (2010) Prospects for minocycline neuroprotection. Arch Neurol 67(12):1442–1448

    Article  PubMed  PubMed Central  Google Scholar 

  • Pulli B, Chen JW (2014) Imaging Neuroinflammation - from bench to bedside. J Clin Cell Immunol 5

    Google Scholar 

  • Rajkowska G, Stockmeier CA (2013) Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14(11):1225–1236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, Machado-Vieira R, Yuan P, Niciu MJ, Lyoo CH, Henter ID, Salvadore G, Drevets WC, Kolb H, Innis RB, Zarate CA Jr (2018) PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res 8(1):57

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Samuni Y, Goldstein S, Dean OM, Berk M (2013) The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830(8):4117–4129

    Article  CAS  PubMed  Google Scholar 

  • Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O’Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A 112:12468–12473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sarris J, Oliver G, Camfield DA, Dean OM, Dowling N, Smith DJ, Murphy J, Menon R, Berk M, Blair-West S, Ng CH (2015) N-acetyl cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study. CNS Drugs 29(9):801–809

    Article  CAS  PubMed  Google Scholar 

  • Saxena S, Brody AL, Schwartz JM, Baxter LR (1998) Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 35:26–37

    Article  Google Scholar 

  • Sayyah M, Boostani H, Pakseresht S, Malayeri A (2011) A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res 189(3):403–406

    Article  CAS  PubMed  Google Scholar 

  • Schou M, Varnas K, Lundquist S, Nakao R, Amini N, Takano A, Finnema SJ, Halldin C, Farde L (2015) Large variation in brain exposure of reference CNS drugs: a PET study in nonhuman primates. Int J Neuropsychopharmacol 18(10):pyv036

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Scott G, Zetterberg H, Jolly A, Cole JH, De Simoni S, Jenkins PO, Feeney C, Owen DR, Lingford-Hughes A, Howes O, Patel MC, Goldstone AP, Gunn RN, Blennow K, Matthews PM, Sharp DJ (2018) Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration. Brain 141(2):459–471

    Article  PubMed  Google Scholar 

  • Seabrook TJ, Jiang L, Maier M, Lemere CA (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53(7):776–782

    Article  PubMed  Google Scholar 

  • Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas PV, Houle S, Meyer JH (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiat 72(3):268–275

    Article  Google Scholar 

  • Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Xu C, Sharma S, Kish S, Houle S, Meyer JH (2018) Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry 5(4):339–347

    Article  PubMed  Google Scholar 

  • Shalbafan M, Mohammadinejad P, Shariat SV, Alavi K, Zeinoddini A, Salehi M, Askari N, Akhondzadeh S (2015) Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 48(4–5):136–140

    CAS  PubMed  Google Scholar 

  • Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH (2004) Anti-basal ganglia antibodies in PANDAS. Mov Disord 19(4):406–415

    Article  PubMed  Google Scholar 

  • Snider LA, Lougee L, Slattery M, Grant P, Swedo SE (2005) Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57(7):788–792

    Article  CAS  PubMed  Google Scholar 

  • Swedo SE (1994) Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 272(22):1788–1791

    Article  CAS  PubMed  Google Scholar 

  • Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155(2):264–271

    Article  CAS  PubMed  Google Scholar 

  • Swedo SE, Leckman JF, Rose NR (2012a) From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Ther 2(2):113

    Article  Google Scholar 

  • Swedo S, Leckman JF, Rose N (2012b) From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut 2:1–8

    Article  Google Scholar 

  • Swedo SE, Leckman JF, Rose NR (2012c) From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut 2:1–8

    Article  Google Scholar 

  • Tachikawa M, Hosoya K, Terasaki T (2014) Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers. Adv Pharmacol 71:337–360

    Article  CAS  PubMed  Google Scholar 

  • Van Weehaeghe D, Van Schoor E, De Voch J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G, Van Laere K (2020) TSPO versus P2X7 as a target for neuroinflammation – an in vitro and in vivo study. J Nucl Med 61(4):604–607

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Venneti S, Wang G, Nguyen J, Wiley CA (2008) The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol 67:1001–1010

    Article  PubMed  Google Scholar 

  • Walker KG, Wilmshurst JM (2010) An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord 3(5):301–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang AK, Miller BJ (2018) Meta-analysis of cerebrospinal fluid cytokine and tryptophan Catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull 44(1):75–83

    Article  PubMed  Google Scholar 

  • Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, Vasdev N (2008) Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35(3):305–314

    Article  CAS  PubMed  Google Scholar 

  • Wolf BJ, Brackhan M, Bascunana P, Leiter I, Langer BLN, Ross TL, Bankstahl JP, Bankstahl M (2020) TSPO PET identifies different anti-inflammatory minocycline treatment response in two rodent models of epileptogenesis. Neurotherapeutics 17(3):1228–1238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, Nandi A, Maris MA, Alexander M, Ye W, Rousset O, Kumar A, Szabo Z, Gjedde A, Grace AA (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33(6):1239–1251

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada

    Jeffrey Meyer

  2. Department of Psychiatry, University of Toronto, Toronto, ON, Canada

    Jeffrey Meyer

Authors
  1. Jeffrey Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey Meyer .

Editor information

Editors and Affiliations

  1. Centre for Health Services and Clinical Research, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK

    Naomi A. Fineberg

  2. Department of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

    Trevor W. Robbins

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meyer, J. (2021). Inflammation, Obsessive-Compulsive Disorder, and Related Disorders. In: Fineberg, N.A., Robbins, T.W. (eds) The Neurobiology and Treatment of OCD: Accelerating Progress. Current Topics in Behavioral Neurosciences, vol 49. Springer, Cham. https://doi.org/10.1007/7854_2020_210

Download citation

Publish with us

Policies and ethics

Search

Navigation